Versant Venture Management

Versant Venture Management as of June 30, 2017

Portfolio Holdings for Versant Venture Management

Versant Venture Management holds 8 positions in its portfolio as reported in the June 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Audentes Therapeutics 27.2 $35M 1.8M 19.14
Achaogen 21.9 $28M 1.3M 21.74
Immune Design 16.8 $21M 2.2M 9.65
Ocular Therapeutix (OCUL) 16.1 $21M 2.2M 9.27
Clovis Oncology 7.5 $9.5M 102k 93.69
Cymabay Therapeutics (CBAY) 4.8 $6.0M 1.0M 5.76
Second Sight Med Prods 4.4 $5.6M 4.5M 1.25
Opgen 1.3 $1.6M 2.6M 0.65